跳至主要内容
临床试验/CTRI/2020/12/030020
CTRI/2020/12/030020尚未招募2 期

A Double Blind Study to Assess Efficacy of Add-on Vitamin D over Escitalopram in Major Depressive Disorder

Pulse Pharmaceuticals Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients suffering from mild to severe depression.
  • 2.18â??65 Years of age, of either gender.
  • 3.Willing to give signed Informed Consent.

排除标准

  • 1.Patients suffering from bipolar affective disorder, any form of schizophrenia, tuberculosis, and sarcoidosis.
  • 2.Pregnant or lactating women.
  • 3.Intake of more than 10 μg vitamin D daily.
  • 4.Known allergy, intolerance or contraindication to study medication.
  • 5.Women of childbearing potential not willing to utilize effective contraception. A negative human chorionic gonadotropin (HCG) pregnancy test is required.
  • 6. Patients were excluded if they at baseline had: serum 25(OH)D <10 nmol/L or >100 nmol/L, serum calcium (ionized) >1.40 mmol/L, estimated glomerular filtration rate (eGFR) <60 mL/min/1.72 m2, serum phosphate <1.50 mmol/L (females) and <1.60 mmol/L (males aged between 18-49 years) or <1.35 mmol/L (males >49 years), or serum parathyroid hormone (PTH) >9.2 pmol/L.

研究者

相似试验